Apollo Hospitals Enterprise · NSE: APOLLOHOSP · BSE: 508869

Q3 FY21 results · Oct–Dec 2020

Apollo Hospitals Enterprise reported revenue from operations of ₹2,759.84 crore and net profit of ₹134.16 crore for Q3 FY21 (Oct–Dec 2020), on a consolidated basis.

Consolidated · ₹ crore
ItemQ3 FY21Q3 FY20YoYQ2 FY21QoQ
Revenue from operations2,759.84——2,760.72−0.0%
Other income5.50——11.32−51.4%
Total income2,765.34——2,772.04−0.2%
Profit before share of associates & JVs and tax169.80——74.85+126.9%
Share of profit/(loss) of associates & JVs15.54—(9.26)
Net profit for the period134.16——58.99+127.4%
Attributable to shareholders of the company130.43——60.27+116.4%
EPS, basic (₹)9.38——4.33+116.6%
Net margin (%)4.9—2.1

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ3 FY21Q3 FY20YoYQ2 FY21QoQ
Revenue from operations2,367.012,529.50−6.4%2,414.45−2.0%
Other income0.933.01−69.1%4.79−80.6%
Total income2,367.942,532.51−6.5%2,419.24−2.1%
Profit before tax155.30145.64+6.6%38.44+304.0%
Net profit for the period106.2294.75+12.1%32.52+226.6%
EPS, basic (₹)7.646.81+12.2%2.34+226.5%
Net margin (%)4.53.71.3
Consolidated
Filed with BSE
13 Feb 2021, 15:15 IST
Board meeting
12 Feb 2021
Period
01 Oct 2020 to 31 Dec 2020
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
13 Feb 2021, 15:15 IST
Board meeting
12 Feb 2021
Period
01 Oct 2020 to 31 Dec 2020
Review status
Unaudited
Source
XBRL filing on BSE